Current challenges in multimodality lung cancer treatment
Symposium Chairs: R.M. Huber (Munich, Germany), D. Subotic (Belgrade, Republic of Serbia)
Aims: The audience will get updated information about the individualised approach related to risk assessment depending on the anticipated surgery, optimal multimodality lung cancer treatment, and some specific situations such as Pancoast tumours requiring a specific approach. Updated information about therapeutic approach in early and very advanced lung cancer will be provided.